Writing in The Guardian, TAI’s own Josef Joffe takes stock of the President-elect’s recent interviews ... The purpose of such a twosome is a hands-on alliance against Isis and a tacit one against China to stop its …
Josef Joffe
It's been a tough year for ISIS Pharmaceuticals investors. After a remarkable 281% return in 2013, shares have gone absolutely nowhere in 2014. That flat-line return is even more disappointing considering that the S&P 500 …
“The wealthy are paying a fairer share of taxes even as the stock market …
Barack Obama
BMO capital has affirmed an Outperform rating for Isis Pharmaceutical, Inc. (NASDAQ: ISIS) stock with a 12 month price target of $75. The rating was based on Isis's announcement on February 5, that it has received …
Matthew M. Reed is Vice President of Foreign Reports, Inc., a Washington, DC-based consulting firm focused on oil and politics in the Middle East. In spite of a year-long U.S.-led bombing campaign, ISIS is still producing …
Islamic State in Iraq and the Levant
The past six weeks haven't been too pretty for shareholders of predominantly clinical-stage biotech stock Isis Pharmaceuticals (NASDAQ: ISIS). Since peaking at a closing price of $77.08 on March 19, 2015, shares have …
Isis
As Fortune detailed in a recent magazine feature ... But the algorithms aren't always sophisticated enough to tell the difference between Isis the stock and ISIS the terrorist organization. Last year, Ionis's CEO (which was …
Fortune
So Mosul residents have taken to the streets by foot to stock up on supplies that had run low as the fighting ... But they reopened only days …
Mosul